The Impact of Antidiabetic Therapies on Diastolic Dysfunction and Diabetic Cardiomyopathy

The Impact of Antidiabetic Therapies on Diastolic Dysfunction and Diabetic Cardiomyopathy

Diabetic cardiomyopathy is more prevalent in people with type 2 diabetes mellitus (T2DM) than previously recognized, while often being characterized by diastolic dysfunction in the absence of systolic dysfunction. This likely contributes to why heart failure with preserved ejection fraction is enric...

Full description

Bibliographic Details
Main Authors: Keshav Gopal, Jadin J. Chahade, Ryekjang Kim, John R. Ussher
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Physiology
Subjects:
type 2 diabetes mellitus
diabetic cardiomyopathy
diastolic function
metformin
glucagon-like peptide-1 receptor agonists
dipeptidyl peptidase 4 inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2020.603247/full

Internet

https://www.frontiersin.org/articles/10.3389/fphys.2020.603247/full

Similar Items